MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 1821-1830 Newer>
The Motley Fool
April 30, 2004
David Meier
Nike, It's Your Move In the continuing saga between the sporting goods retailer and Nike, a simple press release reveals a great deal about how Foot Locker looks to gain a little leverage over Nike. mark for My Articles 180 similar articles
The Motley Fool
April 30, 2004
W.D. Crotty
Ingram Micro Flops The world's largest technology wholesaler, Ingram Micro, did a belly flop in the New York stock exchange pool today. mark for My Articles 441 similar articles
The Motley Fool
April 30, 2004
Mark Mahorney
Coinstar Goes for Change The coin-cashing company Coinstar continues to expand its locations, so it could continue to grow revenue for some time, but is it a wise choice for long term investing? mark for My Articles 28 similar articles
The Motley Fool
April 30, 2004
Will Ashworth
IHOP's Tasty Plan The plan was to make the existing IHOP restaurants more profitable while reducing the costs associated with the previous business model. Judging by the latest news, the company isn't only making the customers happy, but the shareholders as well. mark for My Articles 46 similar articles
The Motley Fool
April 30, 2004
Rich Smith
ServiceMaster Smiles Home maintenance guru ServiceMaster, owner of such well-known brands as American Home Shield, TruGreen, Merry Maids and Terminix, doubled its earnings per share in the first quarter of 2004. mark for My Articles 43 similar articles
The Motley Fool
April 30, 2004
Ben McClure
Duke's Hazards Duke Energy's first-quarter earnings show that the utility giant is living through the merchant energy sector's meltdown but still faces plenty of hazards before it's in the clear. mark for My Articles 254 similar articles
The Motley Fool
April 30, 2004
Charly Travers
Sales Weakness From InterMune Biotechnology company InterMune would seem to be in good shape with a drug, Actimmune (which helps boost the immune system of cancer patients and others). The drug, however, has been showing quarterly sales weakness since early 2003, a trend that now seems like it may continue into the future. mark for My Articles 37 similar articles
The Motley Fool
April 30, 2004
Bill Mann
Google IPO? No Thanks Google is going public but buyer beware. Great companies can have lousy stocks if you buy them at the wrong price. Given the excitement here, that's almost exactly what this promises to be. mark for My Articles 2406 similar articles
The Motley Fool
April 30, 2004
Chris Mallon
It's Good to Be the King Anheuser-Busch is the dominant force in the beer market and has pricing power that its competitors can only mimic. First-quarter results prove, once again, that the ability to raise prices continues to play a big part in the company's success. mark for My Articles 194 similar articles
The Motley Fool
April 30, 2004
Seth Jayson
Flat Panels Fire Up Fuji With leadership positions in digital photography and panel TVs, Fuji is well positioned to take advantage of current technology trends. mark for My Articles 36 similar articles
<Older 1821-1830 Newer>    Return to current articles.